1143571-97-4

Basic information

• Product Name: (Z)-tert-butyl (tert-butoxycarbonylaMino)(4-(4-Methylpiperazin-1-yl)phenylaMino)MethylenecarbaMate
• Synonyms: (Z)-tert-butyl (tert-butoxycarbonylaMino)(4-(4-Methylpiperazin-1-yl)phenylaMino)MethylenecarbaMate
• CAS NO: 1143571-97-4
• Molecular Formula: C₂₂H₃₅N₅O₄
• Molecular Weight: 433.5444
• Mol File: 1143571-97-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (Z)-tert-butyl (tert-butoxycarbonylaMino)(4-(4-Methylpiperazin-1-yl)phenylaMino)MethylenecarbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: (Z)-tert-butyl (tert-butoxycarbonylaMino)(4-(4-Methylpiperazin-1-yl)phenylaMino)MethylenecarbaMate(1143571-97-4)
• EPA Substance Registry System: (Z)-tert-butyl (tert-butoxycarbonylaMino)(4-(4-Methylpiperazin-1-yl)phenylaMino)MethylenecarbaMate(1143571-97-4)

Safety Data

• Hazardous Substances Data: 1143571-97-4(Hazardous Substances Data)

Upstream product

• 16153-81-4 4-(4-Methyl-piperazino)-anilin 
• 152120-54-2 (Z)-tert-butyl (((tert-butoxycarbonyl)imino)(1H-pyrazol-1-yl)methyl)carbamate 
• 152120-54-2 N,N'-bis( tert-butoxycarbonyl)-1H-pyrazole-1-carboxamidine 
• 148546-99-0 3-(4-methylpiperazin-1-yl)aniline 

Downstream Products

• 1142946-16-4 2-(4-(4-methylpiperazin-1-yl)phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-ol 
• 770671-04-0 1-(3-(4-methylpiperazin-1-yl)phenyl)guanidine 
• 219132-76-0 1-(4-(4-methylpiperazin-1-yl)phenyl)guanidine 
• 1147015-04-0 1-isopropyl-7-((2-(4-(4-methylpiperazin-1-yl)phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)ethynyl)-1H-indole-3-carbonitrile 
• 1147015-24-4 4-{[2-methyl-1-(1-methylethyl)-1H-benzimidazol-7-yl]ethynyl}-N-[4-(4-methylpiperazin-1-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-2-amine 
• 1147014-90-1 N-(4-(4-methylpiperazin-1-yl)phenyl)-4-(2-o-tolylethynyl)-7H-pyrrolo[2,3-d]pyrimidin-2-amine 
• 1142946-17-5 ⁽⁰⁸¹⁾C₀₇₅₀₅ 

Relevant articles and documents

Discovery and optimization of a novel series of dyrk1b kinase inhibitors to explore a MEK resistance hypothesis

Potent and selective inhibitors of Dyrk1B kinase were developed to explore the hypothesis, based on siRNA studies, that Dyrk1B may be a resistance mechanism in cells undergoing a stress response.

PYRROLOPYRIMIDINE ALKYNYL COMPOUNDS AND METHODS OF MAKING AND USING SAME

Provided herein are pyrrolopyrimide alkynyl compounds, and methods of making and using the same. Such compounds may be used in inflammatory or myeloproliferative disorders. The disclosure also provides for treating cancer.